Nuclear factor-κB activation in diabetic rat kidney: Evidence for involvement of P-selectin in diabetic nephropathy

Tohoku Journal of Experimental Medicine

Volumn 206, Issue 2, 2005, Pages 163-171

  Iwamoto, Masateru ^a   Mizuiri, Sonoo ^a   Arita, Michitsune ^a   Hemmi, Hiromichi ^a  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Diabetic nephropathy; Nuclear factor B; P selectin; Rat; Streptozotocin

Indexed keywords

ALBUMIN; ANTIOXIDANT; CELL ADHESION MOLECULE; CREATININE; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PADGEM PROTEIN; PROTEIN P50; PROTEIN P52; PYRROLIDINE DITHIOCARBAMATE; RABBIT ANTISERUM; STREPTOZOCIN; SYNAPTOTAGMIN; TRANSCRIPTION FACTOR REL; TRANSCRIPTION FACTOR RELB; PYRROLIDINE DERIVATIVE; PYRROLIDINE DITHIOCARBAMIC ACID; THIOCARBAMIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; DNA PROTEIN COMPLEX; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; HYPERGLYCEMIA; KIDNEY CORTEX; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PROMOTER REGION; PROTEINURIA; RAT; STREPTOZOCIN DIABETES; WESTERN BLOTTING; ANIMAL; BODY WEIGHT; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; WISTAR RAT;

ANIMALS; BODY WEIGHT; DIABETIC NEPHROPATHIES; GENE EXPRESSION REGULATION; MALE; NF-KAPPA B; P-SELECTIN; PYRROLIDINES; RATS; RATS, WISTAR; STREPTOZOCIN; THIOCARBAMATES;

EID: 21244505435     PISSN: 00408727     EISSN: None     Source Type: Journal    
DOI: 10.1620/tjem.206.163     Document Type: Article

References (44)

1. Adamczak, M., Zeier, M., Dikow, R. & Ritz, E. (2002) Kidney and hypertension. Kidney Int. Suppl., 62-67.
2. Bjorck, S., Nyberg, G., Mulec, H., Granerus, G., Herlitz, H. & Aurell, M. (1986) Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. Br. Med. J., 293, 471-474.
3. Bonfanti, R., Furie, B.C., Furie, B. & Wagner, D.D. (1989) PADGEM (GMP140) is a component of Weibel-Palade bodies of human endothelial cells. Blood, 73, 1109-1112.
4. Border, W.A. & Noble, N.A. (1993) Cytokines in kidney disease: The role of transforming growth factor-β. Am. J. Kidney Dis., 22, 105-113.
5. Bradford, M.M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254.
6. Coskun, O., Ocakci, A., Bayraktaroglu, T. & Kanter, M. (2004) Exercise training prevents and protects streptozotocin-induced oxidative stress and β-cell damage in rat pancreas. Tohoku J. Exp. Med., 203, 145-154.
7. Cooper, M.E. (2001) Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy. Diabetologia, 44, 1957-1972.
8. Geng, J.G., Bevilacqua, M.P., Moore, K.L., McIntyre, T.M., Prescott, S.M., Kim, J.M., Bliss, G.A., Zimmerman, G.A. & McEver, R.P. (1990) Rapid neutrophil adhesion to activated endothelium mediated by GMP-140. Nature, 343, 757-760.
9. Grone, H.J., Simon, M. & Grone, E.F. (1995) Expression of vascular endothelial growth factor in renal vascular disease and renal allografts. J. Pathol., 177, 259-267.
10. Guijarro, C. & Egido, J. (2001) Transcription factor-κB (NF-κB) and renal disease. Kidney Int., 59, 415-424.
11. Hasegawa, G., Nakano, K., Sawada, M., Uno, K., Shibayama, Y., Ienaga, K. & Kondo, M. (1991) Possible role of tumor necrosis factor and interleukin-1 in the development of diabetic nephropathy. Kidney Int., 40, 1007-1012.
12. Hirata, K., Shikata, K., Matsuda, M., Akiyama, K., Sugimoto, H., Kushiro, M. & Makino, H. (1998) Increased expression of selectins in kidneys of patients with diabetic nephropathy. Diabetologia, 41, 185-192.
13. Hofmann, M.A., Schiekofer, S., Kanitz, M., Klevesath, M.S., Joswig, M., Lee, V., Morcos, M., Tritschler, H., Ziegler, R., Wahl, P., Bierhaus, A. & Nawroth, P.P. (1998) Insufficient glycemic control increases nuclear factor-κB binding activity in peripheral blood mononuclar cells isolated from patients with type 1 deabetes. Diabetes Care, 21, 1310-1316.
14. Hofmann, M.A., Schiekofer, S., Isermann, B., Kanitz, M., Henkels, M., Joswig, M., Treusch, A., Morcos, M., Weiss, T., Borcea, V., Khalek, A.K., Amiral, J., Tritschler, H., Ritz, E., Wahl, P., Ziegler, R., Bierhaus, A. & Nawroth, P.P. (1999) Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-κB. Diabetologia, 42, 222-232.
15. Jones, S., Jones, S. & Phillips, A.O. (2001) Regulation of renal proximal tubular epithelial cell hyaluronan generation: implications for diabetic nephropathy. Kidney Int., 59, 1739-1749.
16. Keen, H. & Chlouverakis, C. (1963) An immunoassay method for urinary albumin at low concentrations. Lancet, 282, 913-914.
17. Larsen, E., Celi, A., Gilbert, G.E., Furie, B.C., Erban, J.K., Bonfanti, R., Wagner, D.D. & Furie, B. (1989) PADGEM protein: A receptor that mediates the interaction of activated platelets with neutrophils and monocytes. Cell, 59, 305-312.
18. Lenardo, M.J. & Baltimore, D. (1989) NF-κB: A pleiotropic mediator of inducible and tissue-specific gene control. Cell, 58, 227-229.
19. Mizuiri, S., Hemmi, H., Inoue, A., Yoshikawa, H., Tanegashima, M., Fushimi, T., Ishigami, M., Amagasaki, Y., Ohara, T., Shimatake, H. & Hasegawa, A. (1995) Angiotensin-converting enzyme polymorphism and development of diabetic nephropathy in non-insulin-dependent diabetes mellitus. Nephron, 70, 455-459.
20. Mizuiri, S., Hemmi, H., Inoue, A., Takano, M., Kadomatsu, S., Tanimoto, H., Tanegashima, M., Hayashi, I., Fushimi, T. & Hasegawa, A. (1997) Renal hemodynamic changes induced by captopril and angiotensin-converting enzyme gene polymorphism. Nephron, 75, 310-314.
21. Mizuiri, S., Hemmi, H., Kumanomidou, H., Iwamoto, M., Miyagi, M., Sakai, K., Aikawa, A., Ohara, T., Yamada, K., Shimatake, H. & Hasegawa, A. (2001) Angiotensin-converting enzyme (ACE) I/D genotype and renal ACE gene expression. Kidney Int., 60, 1124-1130.
22. Morrissey, J.J. & Klahr, S. (1997) Enalapril decreases nuclear factor-κB activation in the kidney with ureteral obstruction. Kidney Int., 52, 926-933.
23. Narita, T., Koshimura, J., Suzuki, K., Murata, M., Meguro, H., Fujita, H., Kitazato, H. & Ito, S. (1999) Effects of short-term glycemic control, low protein diet and administration of enalapril on renal hemodynamics and protein permselectivity in type 2 diabetic patients with microalbuminuria. Tohoku J. Exp. Med., 189, 117-133.
24. Noh, H., Ha, H., Yu, M.R., Kang, S.W., Choi, K.H., Han, D.S. & Lee, H.Y. (2002) High glucose increases inducible NO production in cultured rat mesangial cells. Possible role in fibronectin production. Nephron, 90, 78-85.
25. Onozato, M.L., Tojo, A., Goto, A., Fujita, T. & Wilcox, C.S. (2002) Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: Effects of ACEI and ARB. Kidney Int., 61, 186-194.
26. Pan, J. & McEver, R.P. (1995) Regulation of the human P-selectin promoter by Bcl-3 and specific homodimeric members of the NF-κB/Rel family. J. Biol. Chem., 270, 23077-23083.
27. Portha, B., Picon, L. & Rosselin, G. (1979) Chemical diabetes in the adult rat as the spontaneous evolution of neonatal diabetes. Diabetologia, 17, 371-377.
28. Portha, B., Blondel, O., Serradas, P., McEvoy, R., Giroix, M.H., Kergoat, M. & Bailbe, D. (1989) The rat models of non-insulin dependent diabetes induced by neonatal streptozotocin. Diabete. Metab., 15, 61-75.
29. Rangan, G.K., Wang, Y., Tay, Y.C. & Harris, D.C. (1999) Inhibition of nuclear factor-κB activation reduces cortical tubulointerstitial injury in proteinuric rats. Kidney Int., 56, 118-134.
30. Rangan, G.K., Wang, Y., Tay, Y.C. & Harris, D.C. (2001) Early administration of PDTC in adriamycin nephropathy: Effect on proteinuria, cortical tubulointerstitial injury, and NF-κB activation. Ren. Fail., 23, 773-780.
31. Rat Genome Sequencing Project Consortium. (2004) Genome sequence of the Brown Norway rat yields insights into mammalian evolution. Nature, 428, 493-521.
32. Satoh, M., Masamune, A., Sakai, Y., Kikuta, K., Hamada, H. & Shimosegawa, T. (2002) Establishment and characterization of a simian virus 40-immortalized rat pancreatic stellate cell line. Tohoku J. Exp. Med., 198, 55-69.
33. Schreck, R., Meier, B., Mannel, D.N., Droge, W. & Baeuerle, P.A. (1992) Dithiocarbamates as potent inhibitors of nuclear factor κB activation in intact cells. J. Exp. Med., 175, 1181-1194.
34. Seron, D., Cameron, J.S. & Haskard, D.O. (1991) Expression of VCAM-1 in the normal and diseased kidney. Nephrol. Dial. Transplant., 6, 917-922.
35. Skill, N.J., Griffin, M., El Nahas, A.M., Sanai, T., Haylor, J.L., Fisher, M., Jamie, M.F., Mould, N.N. & Johnson, T.S. (2001) Increases in renal ε-(γ-glutamyl)-lysine crosslinks result from compartment-specific changes in tissue transglutaminase in early experimental diabetic nephropathy: Pathologic implications. Lab. Invest., 81, 705-716.
36. Sugimoto, H., Shikata, K., Hirata, K., Akiyama, K., Matsuda, M., Kushiro, M., Shikata, Y., Miyatake, N., Miyasaka, M. & Makino, H. (1997) Increased expression of intercellular adhesion molecule-1 (ICAM-1) in diabetic rat glomeruli: Glomerular hyperfiltration is a potential mechanism of ICAM-1 upregulation. Diabetes, 46, 2075-2081.
37. Suzuki, D., Miyazaki, M., Naka, R., Koji, T., Yagame, M., Jinde, K., Endoh, M., Nomoto, Y. & Sakai, H. (1995) In situ hybridization of interleukin 6 in diabetic nephropathy. Diabetes, 44, 1233-1238.
38. Vandendries ER, Furie BC, Furie B. (2004) Role of P-selectin and PSGL-1 in coagulation and thrombosis. Thromb Haemost., 92, 459-466.
39. Wang, T.T., Wu, X.H., Zhang, S.L. & Chan, J.S. (1998) Effect of glucose on the expression of the angiotensinogen gene in opossum kidney cells. Kidney Int., 53, 312-319.
40. Weyrich, A.S., McIntyre, T.M., McEver, R.P., Prescott, S.M. & Zimmerman, G.A. (1995) Monocyte tethering by P-selectin regulates monocyte chemotactic protein-1 and tumor necrosis factor-α secretion. Signal integration and NF-κB translocation. J. Clin. Invest., 95, 2297-2303.
41. Whitty, M.R. & Jackson, B. (1988) Diabetic nephropathy in the rat: Differing renal effects of an angiotensin converting enzyme inhibitor and a calcium inhibitor. Diabetes Res., 8, 91-96.
42. Wolff, S.P. (1993) Diabetes mellitus and free radicals. Free radicals, transition metals and oxidative stress in the aetiology of diabetes mellitus and complications. Br. Med. Bull., 49, 642-652.
43. Yerneni, K.K., Bai, W., Khan, B.V., Medford, R.M. & Natarajan, R. (1999) Hyperglycemia-induced activation of nuclear transcription factor κB in vascular smooth muscle cells. Diabetes, 48, 855-864.
44. Zhang, S.L., Filep, J.G., Hohman, T.C., Tang, S.S., Ingelfinger, J.R. & Chan, J.S. (1999) Molecular mechanisms of glucose action on angiotensinogen gene expression in rat proximal tubular cells. Kidney Int., 55, 454-464.